Sales decline 20.59% to Rs 3.78 crore. Net Loss of Unjha Formulations reported to Rs 0.11 crore in the quarter ended September 2024 as against net loss of Rs 0.12 crore during the ...
Objective: To compare pain control, patient preference and tolerability for two extended-release formulations of morphine sulfate, Kadian ® capsules (administered once daily) and MS Contin ...
Conclusions: In accordance with previous results, this study confirmed the pharmacokinetic differences between a standard ibuprofen tablet formulation and fast-dissolving formulations. Ibuprofen ...